Latest From Biotech Now

As Vaccine Exemptions Rise, Risk of Outbreaks Intensifies

herd-immunity

Generally, we think of vaccines as protecting the vaccinated. We often forget that vaccines, when administered to enough people, protect those in the community who cannot be vaccinated due to certain health conditions, who are too young to be vaccinated, or who experience vaccine failure. This “herd immunity,” as it’s called, is analogous to the concept of ‘safety in numbers’ and is critical to outbreak prevention. However, as reported by Valerie Bauerlein and Betsy McKay Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Mayo v. Prometheus: BIO Statement on Supreme Court Decision

U.S. Supreme Court

By Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization We are surprised and disappointed in the Court’s decision, which disregarded the considered judgment of the Executive Branch experts and numerous amici such as BIO, who warned about the unintended consequences of attempting to use patent eligibility as a basis to strike down these patents for biomarker-based diagnostic methods. While we are still analyzing the opinion, we are concerned that it introduces new and Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Meet 2011′s Buzz of BIO Winner, Amrita Therapeutics

BuzzofBIOLogo

2011 Buzz of BIO Health Winner Amrita Therapeutics is a bio-pharma discovery company based in Ahmedabad, Gujarat, pursuing the development of novel, multiple disease targeting therapies for cancer. Last year, they won the Buzz of BIO Contest for the 2011 BIO International Convention, where industry executives and leaders voted on their favorite biotech companies. BIO recently spoke with Susan Finston, the CEO of Amrita Therapeutics, to get their thoughts on the contest, last year’s BIO Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Patent “Ever-Greening”: Novartis Confronts Patent Myth in India

Pine

India’s ‘increased efficacy’ patentability requirement for medicines prevents an improved form of a known drug from receiving a patent unless the new form is significantly more effective than the previously-known form. This provision aims to accomplish one task: stop patent “ever-greening.”  This issue has risen to prominence lately as the New York Times reports on the Novartis suit challenging patent ever-greening requirements in India’s Supreme Court. So what is patent ever-greening?  Opponents claim that corporations Read More >

Patently BIOtech  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , ,

2012 BIO International Convention Show Daily – Submissions Now Accepted!

BIOSHOW_TUES-FINAL_cover_small

Looking to gain exposure for your company at Convention? Why not submit an article to be considered for the BIOtechNow Show Daily? The BIOtechNow Show Daily is an on-site publication that gets distributed Monday through Thursday at the 2012 BIO International Convention. The daily is distributed in high traffic areas of the Boston Convention & Exhibition Center as well as major hotel lobbies. This “must read” will contain all the hottest breaking news from Convention, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,